Welcome to our dedicated page for Dlh Holdings news (Ticker: DLHC), a resource for investors and traders seeking the latest updates and insights on Dlh Holdings stock.
DLH Holdings Corp. (DLHC) provides technology-driven business process outsourcing and program management solutions for federal health and defense agencies. This news hub offers investors and stakeholders centralized access to official corporate developments and strategic initiatives.
Track all essential updates including earnings reports, federal contract awards, and technology partnerships shaping DLH's position in government health services. Our repository features verified press releases on public sector acquisitions, health IT innovations, and defense logistics programs without promotional bias.
Key updates cover DLH's work with agencies like the Department of Veterans Affairs and Defense Health Agency, emphasizing their digital transformation initiatives in telehealth and analytics. Users gain insights into operational milestones through primary source documents and objective reporting.
Bookmark this page for streamlined monitoring of DLHC's evolving role in federal healthcare solutions. Check regularly for new developments affecting government contracting strategies and public health program management.
DLH Holdings Corp. (NASDAQ: DLHC) reported a revenue increase to $61.5 million for Q2 FY2021, up from $54.8 million in Q2 FY2020, largely due to the acquisition of IBA. Operating margins expanded to 7.5%, with earnings of $2.6 million ($0.19 per share), compared to $2.1 million ($0.16 per share) the previous year. A significant contract award from the VA for $202 million further enhances revenue visibility. The company’s backlog stood at $608.7 million as of March 31, 2021, excluding the new contract.
DLH Holdings Corp. (NASDAQ: DLHC) announced a follow-on contract with the Department of Veterans Affairs worth $202 million to provide medical logistics for the Consolidated Mail Outpatient Pharmacy. This contract spans one year with four optional extensions. It highlights DLH's strong 20-year partnership with the VA and the importance of mail order in veteran care, especially during the COVID-19 pandemic. Last year, the CMOP program processed over 120 million prescriptions nationwide, showcasing DLH's role in improving pharmaceutical delivery to veterans.
DLH Holdings Corp. (NASDAQ: DLHC) will announce its financial results for the fiscal second quarter ending March 31, 2021, on May 5, 2021, after market close. A conference call for investors will be held on May 6, 2021, at 11:00 a.m. ET, where management will discuss the results and operational performance. Interested parties can access the call via phone or through the Investor Relations section of the DLH website, where presentation materials will also be available. DLH specializes in healthcare and human services for federal agencies, employing over 2,200 staff.
DLH Holdings Corp. (NASDAQ: DLHC) will release its fiscal first quarter financial results for the period ending December 31, 2020, on February 2, 2021, after market close. A conference call for investors is scheduled for February 3, 2021, at 11:00 a.m. Eastern Time, featuring senior management discussing financial results and operating trends, followed by a Q&A session. Interested parties can participate by calling 888-347-5290 or 412-317-5256. For more information about DLH’s services and operations, visit www.dlhcorp.com.
DLH Holdings Corp. (NASDAQ: DLHC) has secured a contract valued at up to $42 million to continue operating the AIDS Clinical Trials Group's (ACTG) Network Coordinating Center (NCC), funded by the National Institutes of Health. This contract spans one base year and six option years. DLH, managing the NCC since 1987, provides essential support for HIV research and clinical trials, bolstering public health initiatives. The ACTG network, active in 15 countries, is pivotal in HIV treatment improvements and has recently expanded its research to include studies for COVID-19.
DLH Holdings Corp. (NASDAQ: DLHC) announced its participation in two virtual investor events in Q1 2021. The company will attend the Noble Capital Markets’ 17th Annual Small & Microcap Investor Conference on January 20, and the Alliance Global Partners’ Emerging Growth Technology Conference on February 4. DLH is a leading provider of healthcare services to federal agencies, focusing on technology-enabled health services for military and veterans. Additional details, including presentation materials and opportunities for one-on-one meetings, will be available on the company’s website.
DLH Holdings Corp. (NASDAQ: DLHC) reported fiscal 2020 annual revenue of $209.2 million, up from $160.4 million in 2019, driven by new awards and acquisitions despite COVID-19 impacts. Earnings increased to $0.54 per diluted share from $0.41. Cash flow from operations reached $19.5 million, with a significant debt reduction of $19 million. The acquisition of Irving Burton Associates (IBA) for $32 million added over $140 million to the company’s backlog of $688.4 million.
DLH Holdings Corp. (NASDAQ: DLHC) will announce its financial results for the fiscal fourth quarter ended September 30, 2020, on December 7, 2020, before market opening. The Company will conduct a conference call on the same day at 11:00 a.m. ET, where senior management will discuss financial results and operating trends. Interested listeners can join by dialing 888-347-5290 or 412-317-5256. A replay will be available two hours post-call. DLH specializes in providing healthcare and human services to federal agencies, employing over 2,200 staff nationwide.
DLH Holdings Corp. (NASDAQ: DLHC) will participate in the Truist Virtual Industrials & Services Summit on December 8, 2020. The event will feature one-on-one calls with management, providing opportunities for institutional investors to engage directly with the Company. A presentation will also be accessible on the Company's website.
DLH specializes in innovative healthcare services for federal agencies, focusing on technology-enabled solutions across various health and human services programs, employing approximately 2,000 staff nationwide.
DLH Holdings Corp. (NASDAQ: DLHC) announced the appointment of Sandra Halverson, MPH, PhD, as Chief Scientist effective November 1, 2020. Dr. Halverson, previously Director of the Survey Operations Center, will work with the Executive Leadership Team to shape research priorities and represent the company publicly within the health and life sciences sectors. Her background includes a PhD in Epidemiology and experience as Project Director for the NIEHS Sister Study. The leadership believes her skills will enhance DLH's competitive position amid current public health challenges.
FAQ
What is the current stock price of Dlh Holdings (DLHC)?
What is the market cap of Dlh Holdings (DLHC)?
